These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7772325)

  • 1. The use of interferon alfa-2a for life-threatening hemangiomas.
    MacArthur CJ; Senders CW; Katz J
    Arch Otolaryngol Head Neck Surg; 1995 Jun; 121(6):690-3. PubMed ID: 7772325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alfa-2a therapy for airway hemangiomas.
    Ohlms LA; Jones DT; McGill TJ; Healy GB
    Ann Otol Rhinol Laryngol; 1994 Jan; 103(1):1-8. PubMed ID: 8291854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.
    Ezekowitz RA; Mulliken JB; Folkman J
    N Engl J Med; 1992 May; 326(22):1456-63. PubMed ID: 1489383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of massive or life-threatening hemangiomas with recombinant alpha(2a)-interferon.
    Bauman NM; Burke DK; Smith RJ
    Otolaryngol Head Neck Surg; 1997 Jul; 117(1):99-110. PubMed ID: 9230332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the treatment of hemangiomas in children with interferon alfa-2a.
    Greinwald JH; Burke DK; Bonthius DJ; Bauman NM; Smith RJ
    Arch Otolaryngol Head Neck Surg; 1999 Jan; 125(1):21-7. PubMed ID: 9932582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of parotid hemangiomas to the use of systemic interferon alfa-2a or corticosteroids.
    Blei F; Isakoff M; Deb G
    Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):841-4. PubMed ID: 9260550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon.
    Hatley RM; Sabio H; Howell CG; Flickinger F; Parrish RA
    J Pediatr Surg; 1993 Oct; 28(10):1356-7; discussion 1358-9. PubMed ID: 8263701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a.
    White CW; Wolf SJ; Korones DN; Sondheimer HM; Tosi MF; Yu A
    J Pediatr; 1991 Jan; 118(1):59-66. PubMed ID: 1986099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alpha-2a therapy for disseminated intravascular coagulation in a patient with blue rubber bleb nevus syndrome. A case report.
    Kunishige M; Azuma H; Masuda K; Shigekiyo T; Arii Y; Kawai H; Saito S
    Angiology; 1997 Mar; 48(3):273-7. PubMed ID: 9071205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha-2a therapy of consumptive coagulopathy in Kasabach-Merritt syndrome.
    Klein C; Hauser M; Hadorn HB
    Eur J Pediatr; 1992 Dec; 151(12):919. PubMed ID: 1473549
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful interferon therapy in a neonate with life-threatening Kasabach-Merritt syndrome.
    Nako Y; Fukushima N; Igarashi T; Hoshino M; Sugiyama M; Tomomasa T; Morikawa A
    J Perinatol; 1997; 17(3):244-7. PubMed ID: 9210084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas.
    Tamayo L; Ortiz DM; Orozco-Covarrubias L; Durán-McKinster C; Mora MA; Avila E; Teixeira F; Ruiz-Maldonado R
    Arch Dermatol; 1997 Dec; 133(12):1567-71. PubMed ID: 9420543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha.
    Hesselmann S; Micke O; Marquardt T; Baas S; Bramswig JH; Harms E; Willich N
    Br J Radiol; 2002 Feb; 75(890):180-4. PubMed ID: 11893644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachial plexus paralysis due to giant cavernous hemangioma with Kasabach-Merritt syndrome: successful management with interferon alpha.
    Peker E; Kirimi E; Tuncer O; Ceylan A; Oner AF
    Platelets; 2009 Dec; 20(8):603-5. PubMed ID: 19929246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset].
    González de Dios J; Moya Benavent M; Herranz Sánchez Y; Juste Ruiz M; González Montero R
    An Esp Pediatr; 1996 Feb; 44(2):179-83. PubMed ID: 8830584
    [No Abstract]   [Full Text] [Related]  

  • 16. [Unresectable giant hepatic hemangioma and Kasabach-Merritt syndrome].
    About I; Capdeville J; Bernard P; Lazorthes F; Boneu B
    Rev Med Interne; 1994; 15(12):846-50. PubMed ID: 7863122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hemangiomatosis with recombinant interferon alfa.
    White CW
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):15-22. PubMed ID: 2197730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of infantile hemangiomas with interferon-alpha-2b.
    Chang E; Boyd A; Nelson CC; Crowley D; Law T; Keough KM; Folkman J; Ezekowitz RA; Castle VP
    J Pediatr Hematol Oncol; 1997; 19(3):237-44. PubMed ID: 9201147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood.
    Ricketts RR; Hatley RM; Corden BJ; Sabio H; Howell CG
    Ann Surg; 1994 Jun; 219(6):605-12; discussion 612-4. PubMed ID: 8203969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon for hemangiomas of infancy].
    Segal N; Barak Y
    Harefuah; 1994 Apr; 126(8):438-40, 491-2. PubMed ID: 8070722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.